Results 201 to 210 of about 15,524,849 (357)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

AlphaFold Protein Structure Database 2025: a redesigned interface and updated structural coverage. [PDF]

Nucleic Acids Res
Bertoni D, Tsenkov M, Magana P, Nair S, Pidruchna I, Querino Lima Afonso M, Midlik A, Paramval U, Lawal D, Tanweer A, Last M, Patel R, Laydon A, Lasecki D, Dietrich N, Tomlinson H, Žídek A, Green T, Kovalevskiy O, Lau A, Kandathil S, Bordin N, Sillitoe I, Mirdita M, Jones D, Orengo C, Steinegger M, Fleming JR, Velankar S.   +28 more
europepmc   +1 more source

Tracking Down Software Cluster Bombs: A Current State Analysis of the Free/Libre and Open Source Software (FLOSS) Ecosystem [PDF]

Stefan Tatschner, Michael P. Heinl, Nicole Pappler, Tobias Specht, Sven Plaga, Thomas Newe   +5 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Validation of the BCCT.core Software for Objective Aesthetic Evaluation Following Bilateral Nipple-sparing Mastectomy and Implant-based Reconstruction. [PDF]

Plast Reconstr Surg Glob Open
Carlson GW.
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Usability and expert validation of a virtual reality system for post-mastectomy rehabilitation. [PDF]

Front Rehabil Sci
Bongiorno G, Albi I, Coianiz T, Biancuzzi H, Dal Mas F, Vidi D, Miceli L.   +6 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

The influence of different digital registration methods on measurement accuracy of clear aligner treatment outcomes. [PDF]

BMC Oral Health
Adel SM, El-Harouni N, Kassem HE, Zaher AR, Vaiid N.   +4 more
europepmc   +1 more source

ELABORAÇÃO E TESTE DE QUALIDADE DE CARTAS DE DECLIVIDADE GERADAS A PARTIR DO SOFTWARE SPRING

, 2005
Tatyana Cristina Fraga
openalex   +1 more source